Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 27,688 | 27,169 | 24,851 | 27,665 | 24,345 |
| Operating Income | -27,688 | -27,169 | -24,851 | -27,665 | -24,345 |
| Interest Expense | 1,406 | 1,422 | 1,416 | 1,395 | 1,325 |
| Other Income | 1,055 | 1,517 | 1,697 | 2,027 | 2,323 |
| Pre-tax Income | -28,039 | -27,074 | -24,570 | -27,033 | -23,347 |
| Net Income Continuous | -28,039 | -27,074 | -24,570 | -27,033 | -23,347 |
| Net Income | $-28,039 | $-27,074 | $-24,570 | $-27,033 | $-23,347 |
| EPS Basic Total Ops | -0.44 | -0.41 | -0.39 | -0.44 | -0.38 |
| EPS Basic Continuous Ops | -0.44 | -0.42 | -0.39 | -0.44 | -0.38 |
| EPS Diluted Total Ops | -0.44 | -0.41 | -0.39 | -0.44 | -0.38 |
| EPS Diluted Continuous Ops | -0.44 | -0.42 | -0.39 | -0.44 | -0.38 |
| EPS Diluted Before Non-Recurring Items | -0.44 | -0.42 | -0.39 | -0.44 | -0.38 |
| EBITDA(a) | $-28,197 | $-27,534 | $-25,469 | $-29,045 | $-26,279 |